KYOKO ARATA: Open Payments
NPI 1790234482 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 13 payments from 8 companies in 2025. Trend: 2023 $1,544 · 2024 $1,144 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $293 |
| Gilead Sciences, Inc. | 2 | $125 |
| Amgen Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Exeltis, USA Inc. | 1 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $102 |
| Lilly USA, LLC | 2 | $29 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FARXIGA, KRYSTEXXA, REXULTI, BREZTRI, Biktarvy, TWIRLA, GATTEX, MOUNJARO.
Industry payments across TX — which companies pay providers there.
